Selected Publications

Lucy C, Yimei L, Bhagwat A, Baniewicz D, Leahy AB, Callahan C, Christensen S, Cosey A, DiNofia A, Diorio C, Fraietta J, Gonzalez V, Hexner E, Hunger S, Marshall A, Maude S, McClory S, Myers R, Plesa G, Rheingold S, Sharma A, Stewart M, Wray L, Young-Robinson E, Grupp S, Gill S, Tasian S, Aplenc R: CD123-directed chimeric antigen receptor T-cell (CART123) therapy for relapsed/refractory pediatric acute myeloid leukemia. American Society of Hematology Dec 2025.

Myers RM, Li Y, Liu H, Mumanachit S, Wang L, Leahy AB, Cain LE, DiNofia AM, Diorio C, Freedman JL, Hunger SP, Maude SL, McClory SE, Rheingold SR, Tasian SK, Wray L, Olson TS, Grupp SA, Bunin NJ, Seif AE, Elgarten CW.: Hematopoietic cell transplantation after CD19-directed CAR T-cell therapy for remission consolidation or relapse treatment in pediatric acute lymphoblastic leukemia. Haematologica Nov 2025.

Gibson NM, Elgarten CW, Oved JH, Wray L, Freedman J, Khandros E, Worster E, Nicholas P, Kadauke S, Wang Y, Grupp S, Kwiatkowski JL, Olson TS.: Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with Hemoglobinopathies. Transplant Cell Ther 31(10), Oct 2025.

Myers R, DiNofia AM, Li Y, Diorio C, Liu H, Wertheim G, Fraietta JA, Gonzalez V, Plesa G, Siegel DL, Iannone E, Shinehouse L, Brogdon JL, Taylor C, Jadlowsky JK, Hexner EO, Engels B, Baniewicz D, Callahan C, Ruella M, Aplenc R, Barz Leahy A, McClory SE, Rheingold SR, Wray L, June CH, Maude SL, Frey NV, Grupp SA: CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy. Journal for ImmunoTherapy of Cancer Apr 2025.

Friedes BD, DiNofia AM, Iannone E, Li Y, Rheingold SR, Leahy AB, Wray L, Callahan C, Baniewicz D, Vernau L, Getz KD, Aplenc R, Maude SL, Grupp SA, Myers RM.: Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy. Blood Adv 9: 354-359, Jan 2025.

Diorio C, Hernandez-Miyares L, Espinoza DA, Banwell BL, Bar-Or A, DiNofia AM, Barz Leahy A, Martinez Z, Myers RM, Hopkins SE, Rheingold SR, Teachey DT, Viaene AN, Wray LM, Maude SL, Grupp SA, McGuire JL.: Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood 144: 1387-1398, Sep 2024.

Myers RM, Devine K, Li Y, Lawrence S, Leahy AB, Liu H, Vernau L, Callahan C, Baniewicz D, Kadauke S, McGuire R, Wertheim GB, Kulikovskaya I, Gonzalez VE, Fraietta JA, DiNofia AM, Hunger SP, Rheingold SR, Aplenc R, June CH, Grupp SA, Wray L, Maude SL.: Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia. Blood Adv 8: 2182-2192, May 2024.

Oved JH, Gibson NM, Venella K, Elgarten CW, Wray L, Warren JT, Olson TS.: Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Front Immunol 15: 1369243, Feb 2024.

Elgarten CW, Heidemann S, Freedman JL, Grupp SA, Hankins P, Kadauke S, Li Y, McGlynn B, Olson TS, Wang Y, Wray L, Wang L, Seif AE, Bunin NJ: Pilot Study of Unrelated Donor (URD) Peripheral Stem Cell Transplant (PSCT) with CD45RA-Depleted Addback Following TCRab/CD19 Depletion in Pediatric Patients with Hematologic Malignancies Transplantation and Cellular Therapy 30(2): S9-S10, Feb 2024.

Gibson NM, Elgarten CW, Oved JH, Wray L, Freedman JL, Wang Y, Kadauke S, Hankins P, Nicholas P, Worster E, Kwiatkowski JL, Grupp SA, Bunin NJ, Olson TS: Outcomes of Unrelated Partial T Cell Depleted Stem Cell Transplantation for Patients with Hemoglobinopathies. Transplantation and Cellular Therapy 30(2): S301-S302, Feb 2024.